You are here

580b57fcd9996e24bc43c53e   LinkedIn Logo 500x500   Facebook logo square   Instagram icon

The United Kingdom pharmaceutical industry has set high standards of research, development, manufacturing and testing of its products in order to promote the healthcare of patients. The key factor in the success of the pharmaceutical industry is the quality of the people it employs and the training it provides to ensure the maintenance of the established high standards.

A Qualified Person, who is responsible for certifying the suitability for release of medicinal products as part of this industry, requires specialised training and experience in order to fulfil the requirements.

The Medicines and Healthcare products Regulatory Agency (MHRA) of the Department of Health and the Veterinary Medicines Directorate (VMD) of the Department of the Environment, Food and Rural Affairs (DEFRA), require the Royal Society of Biology, the Royal Pharmaceutical Society and the Royal Society of Chemistry to assess the eligibility of their members for Qualified Person status.

Quarterly Newsletter

The Joint Professional Bodies will be publishing a quarterly newsletter throughout 2022. The aim of this newsletter is to provide regular updates to our members and the public on changes affecting QPs or the QP application process which have been brought about by Brexit and Covid-19. To view the newsletter please click here.

Further information and eligibility is available in the application process section.

The Royal Society of Biology is committed to ensuring equal opportunities in the life sciences, and supports diversity throughout the pipeline; at school and higher education, in the workplace and training.

The Society have reinstated the opt in QP register form for the website displaying QPs regionally. The level of information to be displayed is entirely up to you. Please email the complete form to the QP officer.

Royal Society of Biology QP Register

Email us for further information.